Sono-Tek is trading 5.72% lower at $5.85 after fiscal second-quarter revenue and adjusted EPS missed analyst expectations.
- Revenue was $5.23 million versus $5.56 million expected; adjusted EPS was $0.02 versus $0.04.
- Sono-Tek highlighted 209% medical-market growth and a 23% sequential backlog increase, while reiterating full-year guidance for flat to modest revenue growth.
- Earnings coverage linked the prior-day share decline to results; broader inflation concerns were additional context.